<!DOCTYPE html>
<!--
o o     o     +              o
+   +     +             o     +       +
            +
o  +    +        o  +           +        +
     __  __           _           _     _
~_,-|  \/  | __ _ ___| |__   __ _| |__ | | ___
    | |\/| |/ _` / __| '_ \ / _` | '_ \| |/ _ \,-~_,- - - ,
~_,-| |  | | (_| \__ \ | | | (_| | |_) | |  __/    |   /\_/\
    |_|  |_|\__,_|___/_| |_|\__,_|_.__/|_|\___|  ~=|__( ^ .^)
~_,-~_,-~_,-~_,-~_,-~_,-~_,-~_,-~_,-~_,-~_,-~_,-~_,""   ""
o o     o     +              o
+   +     +             o     +       +
            +
o  +    +        o  +           +        +
-->
<html data-env='production' lang='en' xml:lang='en'>
<head>
<script>
  window.__o = {"channel":"world","content_type":"article","v_buy":null,"v_buy_i":null,"h_pub":7180.0,"h_buy":null,"h_pub_buy":null,"v_cur":0.9,"v_max":1.3,"v_cur_i":0,"v_max_i":1,"events":"event51,event61","top_channel":"world","content_source_type":"Internal","content_source_name":"Internal","author_name":"Katie Sola","age":"299","pub_day":17,"pub_month":8,"pub_year":2014,"pub_date":"08/17/2014","sourced_from":"Internal","isPostView":true,"post_lead_type":"Default","topics":"Ebola,Uncategorized,World","campaign":null,"display_mode":null,"viral_video_type":null,"b_flag":true};
  window._gaq = window._gaq || [];
  window._gaq.push(['_setAccount', 'UA-92124-1']);
  window._geo = "US"
  window.__domStart = (new Date().getTime())
</script>
<title>What Is ZMapp, the Ebola Serum?</title>
<link href="http://rack.2.mshcdn.com/assets/app-465426fc7c803f56f82c984040f1ab07.css" media="screen" rel="stylesheet" type="text/css" />
<link href="http://rack.3.mshcdn.com/assets/posts-a881aa538840e8956b97ad2a35def9f2.css" media="all" rel="stylesheet" type="text/css" />
<!--[if lte IE 8]>
<link href="http://rack.3.mshcdn.com/assets/iehax-957092b11e263c6b850533d06d5aaa2c.css" media="screen" rel="stylesheet" type="text/css" />
<![endif]-->
<meta content='no' name='apple-mobile-web-app-capable'>
<meta content='width=device-width, initial-scale=1.0' name='viewport'>
<link href='https://plus.google.com/113493854651753327245' rel='publisher'>
<link href='http://feeds.mashable.com/Mashable' rel='alternate' title='Mashable' type='application/rss+xml'>
<link href='/apple-touch-icon-57x57.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='57x57'>
<link href='/apple-touch-icon-60x60.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='60x60'>
<link href='/apple-touch-icon-72x72.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='72x72'>
<link href='/apple-touch-icon-76x76.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='76x76'>
<link href='/apple-touch-icon-114x114.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='114x114'>
<link href='/apple-touch-icon-120x120.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='120x120'>
<link href='/apple-touch-icon-144x144.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='144x144'>
<link href='/apple-touch-icon-152x152.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='152x152'>
<link href='/apple-touch-icon-180x180.png?v=m2Pmw8zNwl' rel='apple-touch-icon' sizes='180x180'>
<link href='/favicon-32x32.png?v=m2Pmw8zNwl' rel='icon' sizes='32x32' type='image/png'>
<link href='/android-chrome-192x192.png?v=m2Pmw8zNwl' rel='icon' sizes='192x192' type='image/png'>
<link href='/favicon-96x96.png?v=m2Pmw8zNwl' rel='icon' sizes='96x96' type='image/png'>
<link href='/favicon-16x16.png?v=m2Pmw8zNwl' rel='icon' sizes='16x16' type='image/png'>
<link href='/manifest.json?v=m2Pmw8zNwl' rel='manifest'>
<link href='/favicon.ico?v=m2Pmw8zNwl' rel='shortcut icon'>
<meta content='#da532c' name='msapplication-TileColor'>
<meta content='/mstile-144x144.png?v=m2Pmw8zNwl' name='msapplication-TileImage'>
<meta content='#ffffff' name='theme-color'>
<meta content='mid:12105681' name='linkedin:owner'>
<meta content='122071082108' property='fb:app_id'>
<meta content='18807449704' property='fb:page_id'>
<meta content='nYmtX7H2sSCkK8gHpQGxr7Es2526DgUaqb6PGYSX' name='readability-verification'>
<meta content='app-id=910775754' name='apple-itunes-app'>
<link href='http://rack.3.mshcdn.com/assets/mashable.touchicon-4b641ab8741e4f02da5817297fdaa9b8.png' rel='apple-touch-icon-precomposed'>

<link data-page-subject="true" href="http://mashable.com/2014/08/17/ebola-serum-zmapp/" rel="canonical" /><link data-page-subject="true" href="http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTEyMDB4NjI3IwplCWpwZw/6b5e916b/558/ebola-plant-antibodies.jpg" rel="image_src" /><meta content="http://mashable.com/2014/08/17/ebola-serum-zmapp/" data-page-subject="true" property="og:url" /><meta content="What Is ZMapp, the Ebola Serum?" data-page-subject="true" property="og:title" /><meta content="article" data-page-subject="true" property="og:type" /><meta content="Mashable" data-page-subject="true" property="og:site_name" /><meta content="The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it?" data-page-subject="true" property="og:description" /><meta content="http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTEyMDB4NjI3IwplCWpwZw/6b5e916b/558/ebola-plant-antibodies.jpg" data-page-subject="true" property="og:image" /><meta content="2014-08-17T21:59:36Z" data-page-subject="true" property="og:article:published_time" /><meta content="2014-08-18T16:18:19Z" data-page-subject="true" property="og:article:modified_time" /><meta content="https://www.facebook.com/mashable" data-page-subject="true" property="og:article:publisher" /><meta content="The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it?" data-page-subject="true" name="description" /><meta content="uncategorized, us-world, world, ebola, ebola-outbreak, ebola-virus" data-page-subject="true" name="keywords" /><meta content="What Is ZMapp, the Ebola Serum?" data-page-subject="true" name="twitter:title" /><meta content="The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it?" data-page-subject="true" name="twitter:description" /><meta content="http://rack.1.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTU2MHg3NTAKZQlqcGc/5b15b786/558/ebola-plant-antibodies.jpg" data-page-subject="true" name="twitter:image" /><meta content="@mashable" data-page-subject="true" name="twitter:site" /><meta content="mashable" data-page-subject="true" name="twitter:via" /><meta content="http://mashable.com/2014/08/17/ebola-serum-zmapp/" data-page-subject="true" name="twitter:url" /><meta content="@mashable" data-page-subject="true" name="twitter:creator" /><meta content="photo" data-page-subject="true" name="twitter:card" /><meta content="560" data-page-subject="true" name="twitter:image:width" /><meta content="750" data-page-subject="true" name="twitter:image:height" /><meta content="2014-08-17 21:59:36 UTC" data-page-subject="true" name="date" /><meta content="Katie Sola" data-page-subject="true" name="sailthru.author" /><meta content="http://rack.3.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTExNXgxMTUjCmUJanBn/60a14193/558/ebola-plant-antibodies.jpg" data-page-subject="true" name="sailthru.image.thumb" /><meta content="http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTk1MHg1MzQjCmUJanBn/2a9d24d9/558/ebola-plant-antibodies.jpg" data-page-subject="true" name="sailthru.image.full" /><meta content="http://rack.0.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTYwMHgzMzgjCmUJanBn/00252892/558/ebola-plant-antibodies.jpg" data-page-subject="true" name="sailthru.lead_image" /><meta content="http://rack.3.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTI4OHgxNjIjCmUJanBn/707bdd48/558/ebola-plant-antibodies.jpg" data-page-subject="true" name="sailthru.secondary_image" /><meta content="false" data-page-subject="true" name="sailthru.exclude_homepage" /><meta content="Katie Sola" data-page-subject="true" name="author" /><meta content="http://on.mash.to/1pUp348" data-page-subject="true" name="short_url" /><script type="application/ld+json">{"@context":"http://schema.org","headline":"What Is ZMapp, the Ebola Serum?","url":"http://mashable.com/2014/08/17/ebola-serum-zmapp/","image":"http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTEyMDB4NjI3IwplCWpwZw/6b5e916b/558/ebola-plant-antibodies.jpg","keywords":["uncategorized","us-world","world","ebola","ebola-outbreak","ebola-virus"],"@type":"Article","dateCreated":"2014-08-17T21:59:36Z","datePublished":"2014-08-17T21:59:36Z","articleSection":"world","creator":"Katie Sola","author":"Katie Sola","articleBody":"The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it? A look into the treatment reveals the marvels of biotechnology \u2014 and its limitations.\nZMapp is not a cure or a vaccine. It's a cocktail of genetically engineered antibodies that boosts a patients' ability to fight off Ebola. ZMapp actually combines two different serums made by two different companies. \nThe first serum is called MB-003, and was developed by San Diego firm Mapp Biopharmaceutical. The second goes by the name ZMAb, and was made by Canadian company Defyrus Inc.. When Mapp Biopharmaceutical's commercial arm LeafBio combined the two, MB-003 plus ZMAb became ZMapp. \nSee also: Beware of Fake Ebola Cures Online, FDA Warns\nAntibodies are one of the body's main defenses against viruses and bacteria. When we get sick, our immune system produces antibody cells to tear apart the invaders, and restore us to health.\nEbola is deadly because it disrupts the human immune system. Researchers recently discovered exactly how the virus impairs antibody production. \n\nCreated by Center for Disease Control and Prevention microbiologist Cynthia Goldsmith, this colorized transmission electron micrograph (TEM) reveals some of the ultrastructural morphology displayed by an Ebola virus virion.Image:  CDC/Cynthia GoldsmithDevelopment of MB-003\nAn August 2013 Mapp Biopharmaceutical research paper explains how MB-003 was made, and shows its efficacy in treating Ebola in monkeys. The company has been working with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) on an Ebola treatment, in response to government fears that the virus could be used as a bioweapon. \n\nA doctor for tropical medicine prepares a blood sample for analysis during a demonstration of Ebola-treatment capabilities at Station 59 at Charite hospital on August 11, 2014 in Berlin, Germany.Image: Sean Gallup/Getty ImagesThe first step was for scientists to inject Ebola into mice, and extract three types of antibodies that fight different parts of the virus. It's impossible to inject mouse antibodies into humans because the latter's immune system will attack them as foreign invaders; so scientists spliced in human DNA to produce chimera antibodies acceptable to humans. The result was a serum they called MB-003.\nThe next challenge was producing enough MB-003 for an effective dose. Previous studies found that antibodies could be grown inside genetically engineered Nicotiana Benthamiana, an indigenous Australian tobacco plant, which has also been used to grow West Nile virus antibodies. \nPlants make good hosts because they do not carry viruses that can infect humans, and are cheaper than mammals. Researchers also discovered that plant-grown Ebola antibodies are more effective than those grown inside the ovaries of Chinese hamsters, according to Mapp Biopharmaceutical's study.\n\nImage: Flickr, SmerikalNext, Mapp Biopharmaceutical tested the MB-003 serum on monkeys. Rhesus macaques were injected with Ebola, samples of which were provided by the USAMRIID. One or two days after infection, the monkeys received an intravenous infusion of MB-003. Forty-three percent of the infected monkeys survived. \nDevelopment of ZMab\nDefyrus developed its serum ZMAb in a similar way. ZMAb also contains three antibodies derived from mice, and has been tested in Rhesus Macaques. \nIn June 2012, Defyrus tested ZMAb in Rhesus Macaques, and found that 100% of infected monkeys survived when treated 24 hours after exposure. Fifty percent survived when treated 48 hours after exposure. \nA November 2013 Defyrus study showed that ZMAb offered extended protection against the virus. Scientists reinfected surviving monkeys 10 weeks after their first infection, and 100% survived. What's more, four out of the six monkeys reinfected 13 weeks after initial exposure survived. \nZMapp's origins\nMapp Biopharmaceutical and Defyrus both licensed their serums to Mapp Biopharmaceutical's commercial arm, LeafBio, which combined the two to make ZMapp. \nBefore ZMapp could begin human trials and get approval from the U.S. Food and Drug Administration, the Ebola outbreak began in Guinea when Patient Zero died in December 2013. Since then, the disease has claimed 1,145 lives, according to the World Health Organization. \nTwo American doctors were infected with Ebola through their work in a Liberian hospital with the U.S. aid group Samaritan's Purse. Kent Brantly and Nancy Writbol recovered after receiving ZMapp. However, it's unclear whether the drug helped, or if they are getting better on their own. Around 40% of people infected with Ebola are surviving the current outbreak.\n\nAmerican Ebola patient Dr. Kent Brantly: \"I am growing stronger every day\" http://t.co/NA8EPv0pYA pic.twitter.com/uPPg70NkEm\n\u2014 Mashable (@mashable) August 8, 2014\n\nThe WHO said last Tuesday that use of ZMapp is \"ethical,\" despite the fact that it has never been previously tested on humans. \nHowever, the serum's supply has been exhausted, according to a Defyrus' website. A ZMapp information sheet released by LeafBio and Mapp Biopharmaceutical explains that \"very little of the drug is currently available\" because it has not been evaluated for safety in humans. \nTo gain FDA approval, a drug must undergo three stages of human trials, which means ZMapp is likely years away from FDA approval. \n\"Mapp and its partners are cooperating with appropriate government agencies to increase production as quickly as possible,\" LeafBio said in a  statement on its website. Currently, it's unclear how long it will take to manufacture more of the serum. \nHave something to add to this story? Share it in the comments.\n      window._msla=window.loadScriptAsync||function(src,id){if(document.getElementById(id))return;var js=document.createElement('script');js.id=id;js.src=src;document.getElementsByTagName('script')[0].parentNode.insertBefore(js,fjs);};\n_msla(\"//platform.twitter.com/widgets.js\",\"twitter_jssdk\");","mainEntityOfPage":"True","metadata":{"page":1,"omnitureData":{"channel":"world","content_type":"article","v_buy":null,"v_buy_i":null,"h_pub":7180.0,"h_buy":null,"h_pub_buy":null,"v_cur":0.9,"v_max":1.3,"v_cur_i":0,"v_max_i":1,"events":"event51,event61","top_channel":"world","content_source_type":"Internal","content_source_name":"Internal","author_name":"Katie Sola","age":"299","pub_day":17,"pub_month":8,"pub_year":2014,"pub_date":"08/17/2014","sourced_from":"Internal","isPostView":true,"post_lead_type":"Default","topics":"Ebola,Uncategorized,World","campaign":null,"display_mode":null,"viral_video_type":null,"b_flag":true},"postId":2800237}}</script>

<script src='//cdn.optimizely.com/js/58011369.js'></script>
<script async='async' src='http://widgets.outbrain.com/outbrain.js'></script>
<script src="http://rack.2.mshcdn.com/assets/advertisement-8b541e000d096cdb1fddb739ef2d8a53.js" type="text/javascript"></script>
<script src="http://rack.0.mshcdn.com/assets/app-ac03e9463a7dd12d7c6620eb8d31f281.js" type="text/javascript"></script>
<!--[if lte IE 8]>
<script src="http://rack.2.mshcdn.com/assets/polyfill-6620db93ad92c8f787391361dfe3f23c.js" type="text/javascript"></script>
<![endif]-->
</head>
<body class='body_posts body_show' data-authorid='9595' data-gvmfv='true' data-jsid='posts/show' data-postid='2800237' data-sec0='world' data-sec1='' data-sec2='posts' viewport='fixed'>
<h1 class='semantic'>Mashable</h1>
<header id='flyout-container'></header>
<div id='peek'>
<div id='sticky'>
<div class='cookie-notice'>
<div class='wrap'>
We're using cookies to improve your experience.
<a href="/cookie-policy/" class="cta">Click Here to find out more.</a>
<div class='dismiss'></div>
</div>
</div>


<header id='site-header'><div class='navbar'>
<div class='navbar-inner'><ul class='inline main-menu nav us'>
<li class='menu'><a class='icon-reorder' href='#'></a></li>
<li class='logo us'><a class='brand' data-turbo-target='body-container' href='/'><span>Mashable</span><img alt="Header_logo.v2.us" class="light" src="http://rack.3.mshcdn.com/assets/header_logo.v2.us-30574d105ad07318345ec8f1a85a3efa.png" /><img alt="Header_logo.v2.us.dark" class="dark" src="http://rack.3.mshcdn.com/assets/header_logo.v2.us.dark-5d78b91550b870c7ed82c3497f34947e.png" /></a>
<div class='geos-content'>
<a class='geo' href='?geo=AU' onclick='$.cookie("geo","AU")'>Mashable Australia</a>
<a class='geo' href='?geo=GB' onclick='$.cookie("geo","GB")'>Mashable UK</a>
</div></li>
<li class='submenu collapsable pull-right' id='sign-in'><a href='/login/'><span>Sign in</span></a></li>
<li class='follow submenu follow-menu pull-right'><a class='follow-trigger' href='/2011/11/18/follow-mashable/'><span class='fb'></span>
<span class='tw'></span>
<span class='gp'></span></a>
<div class='dropdown-menu pull-right social-badges'>
<ul>
<li class='facebook-container'>
<a class='social-stub social-share facebook like' data-default='1' data-href='http://facebook.com/mashable' data-shares='2.4m'>Like</a>
</li>
<li>
<a class='twitter-follow-button' data-dnt='true' data-show-count='true' data-show-screen-name='false' href='https://twitter.com/mashable'>
Follow
</a>
</li>
<li class='linked-in'>
<script src='https://platform.linkedin.com/in.js'></script>
<script data-counter='right' data-id='200000' type='IN/FollowCompany'></script>
</li>
<li>
<div class='g-override-container'>
<div class='g-ytsubscribe' data-channel='mashable'></div>
</div>
</li>
<li>
<div class='g-follow' data-annotation='bubble' data-height='20' data-href='//plus.google.com/+Mashable' data-rel='author'></div>
</li>
<li>
<iframe allowtransparency='true' border='0' frameborder='0' height='20' scrolling='no' src='https://platform.tumblr.com/v2/follow_button.html?type=follow-blog&amp;tumblelog=Mashable&amp;color=blue' width='100'></iframe>
</li>
<li>
<div class='pinterest'>
<a data-pin-do='buttonFollow' href='http://www.pinterest.com/Mashable/'>
Mashable
</a>
<script async='true' defer='true' src='https://assets.pinterest.com/js/pinit.js' type='text/javascript'></script>
</div>
</li>
<li>
<iframe id='mkFollowBtn' scrolling='no' seamless='seamless' src='http://meerkatapp.co/btn/follow?style=grande&amp;username=mashable' style='border:none; height: 26px' width='145'></iframe>
</li>
<li>
<a alt='RSS Feed' class='rss' href='http://feeds.mashable.com/Mashable' title='RSS Feed'></a>
<a alt='Email Subscriptions' class='email' href='/subscriptions' title='Email Subscriptions'></a>
<div class='more'>
<a href="/2011/11/18/follow-mashable/">see more&nbsp;&nbsp;&gt;</a></div>
</li>
</ul>
</div></li>
<li class='nav-search submenu pull-right'><a class='search-trigger' href='/search/'>Search</a>
<div class='dropdown-content'>
<div class='page-container'>
<div class='header-search-form'>
<form accept-charset="UTF-8" action="/search/" method="get"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /></div>
<div class='ie-search-wrapper'><input autocomplete="off" class="header-search" id="q" name="q" type="text" value="" /></div>
<input class="btn btn-primary header-search-submit" name="commit" type="submit" value="Search" /></form><div class='header-search-results'></div>
</div>
</div>
</div></li>
<li class='collapsable channel submenu' data-tags='how-to,facebook,twitter,youtube,google-plus'><a href="/social-media/">Social Media</a><div class='submenu-content'></div></li>
<li class='collapsable channel submenu' data-tags='apps-software,dev-design,gadgets,mobile'><a href="/tech/">Tech</a><div class='submenu-content'></div></li>
<li class='collapsable channel submenu' data-tags='advertising,marketing,media,small-business,startups,jobs'><a href="/business/">Business</a><div class='submenu-content'></div></li>
<li class='collapsable channel submenu' data-tags='film,gaming,music,sports,television'><a href="/entertainment/">Entertainment</a><div class='submenu-content'></div></li>
<li class='collapsable channel submenu' data-tags='us,climate,retronaut,space,australia,uk,social-good'><a href="/world/">World</a><div class='submenu-content'></div></li>
<li class='collapsable channel submenu' data-tags='family-parenting,health-fitness,home,travel,work-and-play'><a href="/lifestyle/">Lifestyle</a><div class='submenu-content'></div></li>
<li class='collapsable channel submenu' data-tags='pics,memes,comics,conversations,videos-watercooler'><a href="/watercooler/">Watercooler</a><div class='submenu-content'></div></li>
<li class='submenu more'><a href='#'><!-- %span=t "header.nav.more" -->
<span>More</span></a>
<div class='submenu-content'>
<div class='page-container'>
<ul class='columns'><li><ul class='column-list'><li class='header'>Channels</li>
<li><a href="/social-media/">Social Media</a></li>
<li><a href="/tech/">Tech</a></li>
<li><a href="/business/">Business</a></li>
<li><a href="/entertainment/">Entertainment</a></li>
<li><a href="/world/">World</a></li>
<li><a href="/lifestyle/">Lifestyle</a></li>
<li><a href="/watercooler/">Watercooler</a></li></ul></li><li><ul class='column-list'>
<li class='header'>Company</li><li><a href="/about/">About Us</a></li><li><a href="http://www.wrightsmedia.com/sites/mashable/">Licensing &amp; Reprints</a></li><li><a href="http://mashable.com/2014/">Archive</a></li><li><a href="http://mashable.theresumator.com/">Mashable Careers</a></li></ul></li><li><ul class='column-list'>
<li class='header'>Contact</li><li><a href="/contact-us/">Contact Us</a></li><li><a href="/submit/">Submit News</a></li></ul></li><li><ul class='column-list'>
<li class='header'>Advertise</li><li><a href="/advertise/">Advertise</a></li></ul></li><li><ul class='column-list'>
<li class='header'>Legal</li><li><a href="/privacy/">Privacy Policy</a></li><li><a href="/terms/">Terms of Use</a></li><li><a href="/cookie-policy/">Cookie Policy</a></li></ul></li><li><ul class='column-list'>
<li class='header'>Apps</li><li><a href="https://itunes.apple.com/us/app/mashable/id910775754?mt=8">iPhone / iPad</a></li><li><a href="https://play.google.com/store/apps/details?id=com.mashable.android.phoenix">Android</a></li></ul></li><li><ul class='column-list'>
<li class='header'>Resources</li><li><a href="/2011/11/18/follow-mashable/">Subscriptions</a></li></ul></li><li><ul class='column-list'>
<li class='header'>Sites</li><li><a href="http://findjobs.mashable.com">Jobs</a></li><li><a href="http://events.mashable.com/">Events</a></li><li><a href="http://mashable.com/sgs/">Social Good Summit</a></li><li><a href="http://mashable.com/media-summit/">Media Summit</a></li></ul></li></ul>
</div>
</div></li>
</ul></div>
</div></header>
</div>
<div id='scrollable'><div class='loader'></div>
<div class="ad_container"><span class="ad" data-params="{&quot;tile&quot;:3,&quot;adnum&quot;:3,&quot;sec0&quot;:&quot;world&quot;,&quot;sec1&quot;:&quot;&quot;,&quot;sec2&quot;:&quot;posts&quot;,&quot;postid&quot;:2800237,&quot;gvmfv&quot;:&quot;true&quot;,&quot;authorid&quot;:9595,&quot;type&quot;:&quot;survey&quot;}"></span></div><header class='box970'>
<div class='page-container'><center class='visible-desktop'><div class="ad_container"><span class="ad" data-params="{&quot;tile&quot;:4,&quot;adnum&quot;:1,&quot;sec0&quot;:&quot;world&quot;,&quot;sec1&quot;:&quot;&quot;,&quot;sec2&quot;:&quot;posts&quot;,&quot;postid&quot;:2800237,&quot;gvmfv&quot;:&quot;true&quot;,&quot;authorid&quot;:9595,&quot;type&quot;:&quot;banner&quot;}"></span></div></center></div>
</header>
<div class='posts show' id='body-container'><div id='main'>
<div class='page-container'>

<div id='body'><hgroup class='page-header channel' data-channel='world' data-section='sec0=world&amp;sec1=index&amp;sec2=' id='post-head'>
<h2>World</h2>
<div class='follow-channel'>
<div class='follow-buttons'>
<a class='social-stub social-share facebook like' data-default='1' data-href='http://facebook.com/mashable' data-shares='1.7m'>Like</a>
<a class='social-stub social-share twitter follow' data-shares='3.7m' href='https://twitter.com/intent/follow?region=follow_link&amp;screen_name=mashable&amp;tw_p=followbutton&amp;variant=2.0' target='_blank'>Follow</a>
<div class='g-follow' data-annotation='bubble' data-height='20' data-href='//plus.google.com/+Mashable' data-rel='author'></div>
</div>
</div>
</hgroup>
<div class='flex-box'>
<div class='box-cell'>
<div class='above_960 adsense outside_post'>
<script>
  if(typeof(google_num_ads) != "undefined") google_skip = google_num_ads;
  google_ad_client = "pub-9942038924324175";
  if($('.adsense').last().filter('.above_960').length > 0 && $(document).width() < 960){
    var hideAd = true;
  }else{
    var hideAd = false;
  }
</script>
<script>
  if(!hideAd) google_ad_slot = "3991492827";
</script>
<script>
  if(!hideAd) google_ad_width = 728;
</script>
<script>
  if(!hideAd) google_ad_height = 15;
</script>
<script src='http://pagead2.googlesyndication.com/pagead/show_ads.js'></script>
</div>

<div id='post-content'>
<div id='post-slider'><article class='full post' data-channel='world' data-id='53f125d112d2cd6b0b00006a' data-subchannels='' data-topic='' data-velocity='989,986,982,977,971,965,960,955,949,943,937,930,923,925,918,901,893,885,878,871,865,860,855,842,837,832,826,820,815,809,803,798,792,786,780,774,767,763,757,752,747,742,736,723,717,703,698,692,687,681' data-wp-id='2800237' id='story'>
<header class='article-header'>
<h1 class='title' href='http://mashable.com/2014/08/17/ebola-serum-zmapp/'>What Is ZMapp, the Ebola Serum?</h1>
<aside class='shares social'>
<div class='total-shares' data-index='0'>
<em>1.8k</em>
<div class='caption'>Shares</div>
</div>
<div class='share-buttons'>
<div class='share-button-boxy'><a class="social-stub social-share facebook" data-layout="box_count" data-shares="377" data-uid="bKt7" href="#">Share</a></div>
<div class='share-button-boxy'><a class="social-stub social-share twitter" data-shares="1153" data-uid="bKt7" href="https://twitter.com/intent/tweet?original_referer=http://mashable.com/&amp;source=tweetbutton&amp;text=What+Is+ZMapp%2C+the+Ebola+Serum%3F&amp;url=http%3A%2F%2Fmashable.com%2F2014%2F08%2F17%2Febola-serum-zmapp%2F&amp;via=mashable">Tweet</a></div>
<div class='share-button-boxy'><a class="social-stub social-share google_plus" data-shares="64" data-size="tall" data-uid="bKt7" href="#">Share</a></div>
<div class='share-button-boxy'><a class="social-stub social-share linked_in" data-shares="45" data-uid="bKt7" href="#"></a></div>
<div class='share-button-boxy'><a class="social-stub social-share stumble_upon" data-shares="118" data-uid="bKt7" href="#"></a></div>
<div class='share-button-boxy'><a class="social-stub social-share pinterest" data-shares="0" data-uid="bKt7" href="#"></a></div>
</div>
<div class='velocity-graph tooltip-trigger' title='The Mashable Velocity graph shows how quickly people are sharing this article on the social Web.'>
<canvas class='velocity'></canvas>
<div class='caption'>What's This?</div>
</div>
</aside>

<div class='above_960 adsense'>
<script>
  if(typeof(google_num_ads) != "undefined") google_skip = google_num_ads;
  google_ad_client = "pub-9942038924324175";
  if($('.adsense').last().filter('.above_960').length > 0 && $(document).width() < 960){
    var hideAd = true;
  }else{
    var hideAd = false;
  }
</script>
<script>
  if(!hideAd) google_ad_channel = "9077376301";
</script>
<script>
  if(!hideAd) google_ad_output = "js";
</script>
<script>
  if(!hideAd) google_max_num_ads = "3";
</script>
<script>
  if(!hideAd) google_ad_type = "text";
</script>
<script>
  if(!hideAd) google_feedback = "on";
</script>
<script src='http://pagead2.googlesyndication.com/pagead/show_ads.js'></script>
</div>

<figure class='article-image'><img alt="Ebola-plant-antibodies" class="microcontent" data-fragment="lead-image" data-image="http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTk1MHg1MzQjCmUJanBn/2a9d24d9/558/ebola-plant-antibodies.jpg" data-micro="1" data-url="null" src="http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTk1MHg1MzQjCmUJanBn/2a9d24d9/558/ebola-plant-antibodies.jpg" /><figcaption class="image-caption">A biotech greenhouse associate replaces young tobacco plants of a unique strain in the greenhouse at Medicago USA, Inc. </figcaption><div class="image-credit">Image: <a href="http://www.apimages.com/metadata/Index/Ebola-Plant-Medicines/a2f41f3c632944749100df6d8872a9cd/25/0" target="_blank">Gerry Broome/Associated Press</a></div></figure>

<div class="article-info"><a class="byline" href="/people/katie-sola/"><img alt="Me" class="author_image" src="http://rack.3.mshcdn.com/media/ZgkyMDE0LzA3LzA3LzllL01FLmIxYTQzLmpwZwpwCXRodW1iCTkweDkwIwplCWpwZw/51a86755/f85/ME.jpg" /><div class="author_and_date"><span class="author_name">By Katie Sola</span><time datetime="Sun, 17 Aug 2014 21:59:36 +0000">2014-08-17 21:59:36 UTC</time></div></a></div>

</header>
<section class='article-content'>

<p>The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it? A look into the treatment reveals the marvels of biotechnology — and its limitations.</p>
<p>ZMapp is not a cure or a vaccine. It's a cocktail of genetically engineered antibodies that boosts a patients' ability to fight off Ebola. ZMapp actually <a href="http://www.mappbio.com/ZMAb.pdf" target="_blank">combines</a> two different serums made by two different companies. </p>
<p>The first serum is called MB-003, and was developed by San Diego firm <a href="http://www.mappbio.com/" target="_blank">Mapp Biopharmaceutical</a>. The second goes by the name ZMAb, and was made by Canadian company <a href="http://www.defyrus.com/index.html" title="Defyrus Inc." target="_blank">Defyrus Inc.</a>. When Mapp Biopharmaceutical's commercial arm LeafBio combined the two, MB-003 plus ZMAb became ZMapp. </p>
<div class="see-also"><p>See also: <a href="http://mashable.com/2014/08/15/fake-ebola-cures-fda/" data-crackerjax="#post-slider">Beware of Fake Ebola Cures Online, FDA Warns</a></p></div>
<p>Antibodies are one of the body's main defenses against viruses and bacteria. When we get sick, our immune system produces antibody cells to tear apart the invaders, and restore us to health.</p>
<p>Ebola is deadly because it disrupts the human immune system. Researchers recently discovered <a href="http://www.eurekalert.org/pub_releases/2014-08/cp-ruh081114.php" title="exactly how" target="_blank">exactly how</a> the virus impairs antibody production. </p>
<figure class="image"><p><img data-credit-link="http://phil.cdc.gov/phil/details.asp?pid=10816" data-credit-name="CDC/Cynthia Goldsmith" data-credit-label="" data-credit-provider="Custom type" data-caption="Created by Center for Disease Control and Prevention microbiologist Cynthia Goldsmith, this colorized transmission electron micrograph (TEM) reveals some of the ultrastructural morphology displayed by an Ebola virus virion." title="Ebola_virus" src="http://rack.0.mshcdn.com/media/ZgkyMDE0LzA4LzE2LzcwL0Vib2xhX3ZpcnVzLjNlYzJmLmpwZwpwCXRodW1iCTEyMDB4OTYwMD4/dd851919/136/Ebola_virus.jpg" alt="Ebola virus micrograph" class="" data-width="1920" data-fragment="m!cb19" data-image="http://rack.0.mshcdn.com/media/ZgkyMDE0LzA4LzE2LzcwL0Vib2xhX3ZpcnVzLjNlYzJmLmpwZwpwCXRodW1iCTEyMDB4OTYwMD4/dd851919/136/Ebola_virus.jpg" data-micro="1"></p>
<figcaption class="image-caption"><p>Created by Center for Disease Control and Prevention microbiologist Cynthia Goldsmith, this colorized transmission electron micrograph (TEM) reveals some of the ultrastructural morphology displayed by an Ebola virus virion.</p></figcaption><div class="image-credit"><p>Image:  <a href="http://phil.cdc.gov/phil/details.asp?pid=10816" target="_blank">CDC/Cynthia Goldsmith</a></p></div></figure><h3>Development of MB-003</h3>
<p>An August 2013 <a href="http://www.mappbio.com/publications.html" target="_blank">Mapp Biopharmaceutical</a> <a href="http://stm.sciencemag.org/content/5/199/199ra113.full.pdf?keytype=ref&amp;siteid=scitransmed&amp;ijkey=0sAYN4XJB0f5s" title="study" target="_blank">research paper</a> explains how MB-003 was made, and shows its efficacy in treating Ebola in monkeys. The company has been working with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) on an Ebola treatment, in response to government fears that the virus could be used as a bioweapon. </p>
<figure class="image"><p><img data-credit-link="" data-credit-name="Sean Gallup/Getty Images" data-credit-provider="Getty" data-caption="A doctor for tropical medicine prepares a blood sample for analysis during a demonstration of Ebola-treatment capabilities at Station 59 at Charite hospital on August 11, 2014 in Berlin, Germany." title="Ebola Treatment Ethical" src="http://rack.0.mshcdn.com/media/ZgkyMDE0LzA4LzE2Lzk0L0Vib2xhVHJlYXRtLmU2MGE4LmpwZwpwCXRodW1iCTEyMDB4OTYwMD4/6e4dee2d/5b8/Ebola-Treatment-Ethical.jpg" alt="Ebola Treatment Ethical" class="" data-width="1920" data-fragment="m!fb72" data-image="http://rack.0.mshcdn.com/media/ZgkyMDE0LzA4LzE2Lzk0L0Vib2xhVHJlYXRtLmU2MGE4LmpwZwpwCXRodW1iCTEyMDB4OTYwMD4/6e4dee2d/5b8/Ebola-Treatment-Ethical.jpg" data-micro="1"></p>
<figcaption class="image-caption"><p>A doctor for tropical medicine prepares a blood sample for analysis during a demonstration of Ebola-treatment capabilities at Station 59 at Charite hospital on August 11, 2014 in Berlin, Germany.</p></figcaption><div class="image-credit"><p>Image: Sean Gallup/Getty Images</p></div></figure><p>The first step was for scientists to inject Ebola into mice, and extract three types of antibodies that fight different parts of the virus. It's impossible to inject mouse antibodies into humans because the latter's immune system will attack them as foreign invaders; so scientists spliced in human DNA to produce chimera antibodies acceptable to humans. The result was a serum they called MB-003.</p>
<p>The next challenge was producing enough MB-003 for an effective dose. Previous studies found that antibodies could be grown inside genetically engineered <em>Nicotiana Benthamiana</em>, an indigenous Australian tobacco plant, which has also been used <a href="http://news.wustl.edu/news/Pages/20188.aspx" title="to grow" target="_blank">to grow</a> West Nile virus antibodies. </p>
<p>Plants make good hosts because they do not carry viruses that can infect humans, and are cheaper than mammals. Researchers also discovered that plant-grown Ebola antibodies are more effective than those grown inside the ovaries of Chinese hamsters, according to Mapp Biopharmaceutical's study.</p>
<figure class="image"><p><img data-credit-link="https://www.flickr.com/photos/smerikal/7635017722/in/photolist-nbnHFP-nbntJT-cXPr45-vv8Kf-cCFsLA-cCFtaE-vv8LS-KMyqP-du1k9T-dRpeG2-8XnYdQ-8VAqAv-8VAqRg-8VAqkr-8VAokX-8VDqJm-8VAqvx-8VDqA9-4ZQbjk-fpbz1e-eHkeSF-4ho4az-rmvxq-4ho53z-4hsbCC-4hs8ud-4ho5fT-6tQFaU-vvef2-6tFX8W-6tBPq4-7rcTEo-6BNa8P-6hn4Li-6hn4CT-6hrems-b5quFv-5HYCcB-7WnWQ7-7r8Yc2-fPacqd-fPaec1-fPaeWC-fPacvC-fPafKN-fNSE8z-fPafjE-fNSEWn-fNSHuK-fPaf5q" data-credit-name="Smerikal" data-credit-provider="Flickr" data-caption="" title="" src="http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE2L2Y2L3JoZXN1c21vbmtlLjkxNTlkLmpwZwpwCXRodW1iCTEyMDB4OTYwMD4/52b8d159/97b/rhesus-monkey.jpg" alt="" class="" data-width="1920" data-fragment="m!5462" data-image="http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE2L2Y2L3JoZXN1c21vbmtlLjkxNTlkLmpwZwpwCXRodW1iCTEyMDB4OTYwMD4/52b8d159/97b/rhesus-monkey.jpg" data-micro="1"></p>
<div class="image-credit"><p>Image: Flickr, <a href="https://www.flickr.com/photos/smerikal/7635017722/in/photolist-nbnHFP-nbntJT-cXPr45-vv8Kf-cCFsLA-cCFtaE-vv8LS-KMyqP-du1k9T-dRpeG2-8XnYdQ-8VAqAv-8VAqRg-8VAqkr-8VAokX-8VDqJm-8VAqvx-8VDqA9-4ZQbjk-fpbz1e-eHkeSF-4ho4az-rmvxq-4ho53z-4hsbCC-4hs8ud-4ho5fT-6tQFaU-vvef2-6tFX8W-6tBPq4-7rcTEo-6BNa8P-6hn4Li-6hn4CT-6hrems-b5quFv-5HYCcB-7WnWQ7-7r8Yc2-fPacqd-fPaec1-fPaeWC-fPacvC-fPafKN-fNSE8z-fPafjE-fNSEWn-fNSHuK-fPaf5q" target="_blank">Smerikal</a></p></div></figure><p>Next, Mapp Biopharmaceutical tested the MB-003 serum on monkeys. Rhesus macaques were injected with Ebola, samples of which were provided by the USAMRIID. One or two days after infection, the monkeys received an intravenous infusion of MB-003. Forty-three percent of the infected monkeys survived. </p>
<h3>Development of ZMab</h3>
<p>Defyrus developed its serum ZMAb in a similar way. ZMAb also contains three antibodies derived from mice, and has been tested in Rhesus Macaques. </p>
<p>In June 2012, Defyrus <a href="http://stm.sciencemag.org/content/4/138/138ra81.short" title="similar study" target="_blank">tested</a> ZMAb in Rhesus Macaques, and found that 100% of infected monkeys survived when treated 24 hours after exposure. Fifty percent survived when treated 48 hours after exposure. </p>
<p>A November 2013 Defyrus <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842534/" title="study" target="_blank">study</a> showed that ZMAb offered extended protection against the virus. Scientists reinfected surviving monkeys 10 weeks after their first infection, and 100% survived. What's more, four out of the six monkeys reinfected 13 weeks after initial exposure survived. </p>
<h3>ZMapp's origins</h3>
<p>Mapp Biopharmaceutical and Defyrus both licensed their serums to Mapp Biopharmaceutical's commercial arm, <a href="http://www.leafbio.com/" title="LeafBio" target="_blank">LeafBio</a>, which combined the two to make ZMapp. </p>
<p>Before ZMapp could begin human trials and get approval from the U.S. Food and Drug Administration, the Ebola outbreak began in Guinea when Patient Zero <a href="http://www.cnn.com/2014/08/11/health/ebola-patient-zero/" title="died" target="_blank">died</a> in December 2013. Since then, the disease has claimed 1,145 lives, according to the <a href="http://www.cdc.gov/vhf/ebola/outbreaks/guinea/" title="Center for Disease Control" target="_blank">World Health Organization</a>. </p>
<p>Two American doctors were infected with Ebola through their work in a Liberian hospital with the U.S. aid group Samaritan's Purse. <a href="http://mashable.com/2014/08/08/american-ebola-patient/" title="Kent Brantly" data-crackerjax="#post-slider">Kent Brantly</a> and Nancy Writbol recovered after receiving ZMapp. However, it's unclear whether the drug helped, or if they are getting better on their own. Around <a href="http://mashable.com/2014/08/12/ebola-ethical-who/">40% of people infected with Ebola are surviving the current outbreak</a>.</p>
<blockquote class="twitter-tweet" lang="en">
<p>American Ebola patient Dr. Kent Brantly: "I am growing stronger every day" <a href="http://t.co/NA8EPv0pYA" target="_blank">http://t.co/NA8EPv0pYA</a> <a href="http://t.co/uPPg70NkEm" target="_blank">pic.twitter.com/uPPg70NkEm</a></p>
<p>— Mashable (@mashable) <a href="https://twitter.com/mashable/statuses/497835101695512576" target="_blank">August 8, 2014</a></p>
</blockquote>
<p>The WHO <a href="http://mashable.com/2014/08/12/ebola-ethical-who/" data-crackerjax="#post-slider">said last Tuesday</a> that use of ZMapp is "ethical," despite the fact that it has never been previously tested on humans. </p>
<p>However, the serum's supply has been exhausted, according to a Defyrus' <a href="http://www.defyrus.com/" title="website" target="_blank">website</a>. A <a href="http://www.defyrus.com/images/ZMapp-information-sheet.pdf" title="ZMapp" target="_blank">ZMapp information sheet</a> released by LeafBio and Mapp Biopharmaceutical explains that "very little of the drug is currently available" because it has not been evaluated for safety in humans. </p>
<p>To gain FDA approval, a drug must undergo three stages of <a href="http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm289601.htm" title="human trials" target="_blank">human trials</a>, which means ZMapp is likely years away from FDA approval. </p>
<p>"Mapp and its partners are cooperating with appropriate government agencies to increase production as quickly as possible," LeafBio said in a <a href="http://www.leafbio.com/zmapinfo.pdf" title="statement" target="_blank"> statement</a> on its website. Currently, it's unclear how long it will take to manufacture more of the serum. </p>
<p><em>Have something to add to this story? Share it in the comments.</em></p>
<script>      window._msla=window.loadScriptAsync||function(src,id){if(document.getElementById(id))return;var js=document.createElement('script');js.id=id;js.src=src;document.getElementsByTagName('script')[0].parentNode.insertBefore(js,fjs);};
_msla("//platform.twitter.com/widgets.js","twitter_jssdk");</script>



</section>
<footer class='article-topics'>
Topics:
<a href="/category/ebola/">Ebola</a>, <a href="/category/world/">World</a>
</footer>
<div id='outbrain-container'>
<div class='OUTBRAIN' data-ob-template='mashable' data-src='http://mashable.com/2014/08/17/ebola-serum-zmapp/' data-widget-id='AR_3'></div>
</div>
<div data-display-daily-newsletter='show' id='newsletter-signup'></div>

<script>
  if(window.pageChanged)
    window.omni({"channel":"world","content_type":"article","v_buy":null,"v_buy_i":null,"h_pub":7180.0,"h_buy":null,"h_pub_buy":null,"v_cur":0.9,"v_max":1.3,"v_cur_i":0,"v_max_i":1,"events":"event51,event61","top_channel":"world","content_source_type":"Internal","content_source_name":"Internal","author_name":"Katie Sola","age":"299","pub_day":17,"pub_month":8,"pub_year":2014,"pub_date":"08/17/2014","sourced_from":"Internal","isPostView":true,"post_lead_type":"Default","topics":"Ebola,Uncategorized,World","campaign":null,"display_mode":null,"viral_video_type":null,"b_flag":true});
    metaData = {"link":[["canonical","http://mashable.com/2014/08/17/ebola-serum-zmapp/"],["image_src","http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTEyMDB4NjI3IwplCWpwZw/6b5e916b/558/ebola-plant-antibodies.jpg"]],"meta_property":[["og:url","http://mashable.com/2014/08/17/ebola-serum-zmapp/"],["og:title","What Is ZMapp, the Ebola Serum?"],["og:type","article"],["og:site_name","Mashable"],["og:description","The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it?"],["og:image","http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTEyMDB4NjI3IwplCWpwZw/6b5e916b/558/ebola-plant-antibodies.jpg"],["og:article:published_time","2014-08-17T21:59:36Z"],["og:article:modified_time","2014-08-18T16:18:19Z"],["og:article:publisher","https://www.facebook.com/mashable"]],"meta_name":[["description","The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it?"],["keywords","uncategorized, us-world, world, ebola, ebola-outbreak, ebola-virus"],["twitter:title","What Is ZMapp, the Ebola Serum?"],["twitter:description","The media has been buzzing about ZMapp, widely reported as an experimental top-secret, untested Ebola serum. But what is it?"],["twitter:image","http://rack.1.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTU2MHg3NTAKZQlqcGc/5b15b786/558/ebola-plant-antibodies.jpg"],["twitter:site","@mashable"],["twitter:via","mashable"],["twitter:url","http://mashable.com/2014/08/17/ebola-serum-zmapp/"],["twitter:creator","@mashable"],["twitter:card","photo"],["twitter:image:width","560"],["twitter:image:height","750"],["date","2014-08-17 21:59:36 UTC"],["sailthru.author","Katie Sola"],["sailthru.image.thumb","http://rack.3.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTExNXgxMTUjCmUJanBn/60a14193/558/ebola-plant-antibodies.jpg"],["sailthru.image.full","http://rack.2.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTk1MHg1MzQjCmUJanBn/2a9d24d9/558/ebola-plant-antibodies.jpg"],["sailthru.lead_image","http://rack.0.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTYwMHgzMzgjCmUJanBn/00252892/558/ebola-plant-antibodies.jpg"],["sailthru.secondary_image","http://rack.3.mshcdn.com/media/ZgkyMDE0LzA4LzE4L2M2L2Vib2xhcGxhbnRhLjRkMmE0LmpwZwpwCXRodW1iCTI4OHgxNjIjCmUJanBn/707bdd48/558/ebola-plant-antibodies.jpg"],["sailthru.exclude_homepage",false],["author","Katie Sola"]],"short_url":[["short_url","http://on.mash.to/1pUp348"]]};
</script>
<div class='right_rail_replace'>
<div class="ad_container"><span class="ad" data-params="{&quot;tile&quot;:1,&quot;adnum&quot;:1,&quot;sec0&quot;:&quot;world&quot;,&quot;sec1&quot;:&quot;&quot;,&quot;sec2&quot;:&quot;posts&quot;,&quot;postid&quot;:2800237,&quot;gvmfv&quot;:&quot;true&quot;,&quot;authorid&quot;:9595,&quot;type&quot;:&quot;no_right_rail&quot;}"></span></div>
</div>
</article>
</div>
<div class='article-comments limit-comments'>
<div data-article-id="53f125d112d2cd6b0b00006a" data-checksum="a4f11300e8807a922a75303289968721" data-collection-meta="eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJ0aXRsZSI6IldoYXQgSXMgWk1hcHAsIHRoZSBFYm9sYSBTZXJ1bT8iLCJ1cmwiOiJodHRwOi8vbWFzaGFibGUuY29tLzIwMTQvMDgvMTcvZWJvbGEtc2VydW0tem1hcHAvIiwidGFncyI6InVuY2F0ZWdvcml6ZWQsdXMtd29ybGQsd29ybGQsZWJvbGEsZWJvbGEtb3V0YnJlYWssZWJvbGEtdmlydXMiLCJjaGVja3N1bSI6ImE0ZjExMzAwZTg4MDdhOTIyYTc1MzAzMjg5OTY4NzIxIiwiYXJ0aWNsZUlkIjoiNTNmMTI1ZDExMmQyY2Q2YjBiMDAwMDZhIn0.5AFI0Ap_R1Supe42-pDJC2kYHdRqDfPS8UcB8PLCrlw" data-network="mashable.fyre.co" data-root="zor.livefyre.com" data-site-id="312274" id="livefyre_comments"></div>
<a class='btn btn-light load-comments' href='#'>Load Comments</a>
<div id='powered_by_livefyre_new'>
<a href='http://livefyre.com' target='_blank'>Powered by Livefyre</a>
</div>
</div>
</div>
</div>
<aside class='box-cell sidebar'>
<div class='ad sidebar-inset sidebar-drop'>
<div class="ad_container"><span class="ad" data-params="{&quot;tile&quot;:2,&quot;adnum&quot;:1,&quot;sec0&quot;:&quot;world&quot;,&quot;sec1&quot;:&quot;&quot;,&quot;sec2&quot;:&quot;posts&quot;,&quot;postid&quot;:2800237,&quot;gvmfv&quot;:&quot;true&quot;,&quot;authorid&quot;:9595,&quot;type&quot;:&quot;right_rail&quot;}"></span></div>

</div>
<h1 class='ribbon hot'>What's Hot</h1>
<div class='sidebar-inset' id='big-stories'></div>
</aside>
</div>
<div id='more-in-channel'>
<div class='page-header channel' data-channel='world' data-section='sec0=world&amp;sec1=index&amp;sec2='>
<h2>More in World</h2>
</div>
<div class='fixable-wrapper' id='column-headers'>
<div class='column-headers'>
<div class='headers'>
<div class='header column1 waypoint' data-fixselector='header.fixable'><a data-short='New' href='#'>
<em>What's New</em>
</a></div>
<div class='header column2 waypoint' data-fixselector='header.fixable'><a data-short='Rising' href='#'>
<em>What's Rising</em>
</a></div>
<div class='header column3 waypoint' data-fixselector='header.fixable'><a data-short='Hot' href='#'>
<em>What's Hot</em>
</a></div>
</div>
</div>
</div>
<div class='slide-window'>
<div class='flex-box columns'><section class='column box-cell new-stories' id='column-new'><h1 class='semantic'>What's New</h1>
<div class='column-content'></div></section><section class='column box-cell hot-stories' id='column-rising'><h1 class='semantic'>What's Rising</h1>
<div class='column-content'></div></section><section class='column box-cell big-stories' id='column-hot'><h1 class='semantic'>What's Hot</h1>
<div class='column-content'></div></section></div>
</div>
</div>

<script>
  loadScriptAsync("//platform.twitter.com/oct.js", "twitteroct")
  var timer;
  timer = every(500, function() {
    if ((typeof twttr !== "undefined" && twttr !== null) && (twttr.conversion != null)) {
      clearInterval(timer);
      return twttr.conversion.trackPid('l4o6d');
    }
  });
</script>
<noscript>
<img alt='' height='1' src='https://analytics.twitter.com/i/adsct?txn_id=l4o6d&amp;p_id=Twitter' style='display:none;' width='1'>
<img alt='' height='1' src='//t.co/i/adsct?txn_id=l4o6d&amp;p_id=Twitter' style='display:none;' width='1'>
</noscript>

</div>
</div>
</div><div id='fb-root'></div><script>
  if(window.initPage) { window.initPage() }
  else { $(function() { window.initPage(); })}
</script>
</div><footer id='site-footer-wrapper'>
<div class='page-container' id='site-footer'><ul class='nav'><li><a href="/about/">About Us</a></li><li><a href="http://findjobs.mashable.com">Jobs</a></li><li><a href="/advertise/">Advertise</a></li><li><a href="/2011/05/09/connect-with-mashable/">Subscribe</a></li><li><a href="/privacy/">Privacy</a></li><li><a href="/terms/">Terms</a></li></ul><ul class='social'><li><a class='facebook' href='http://www.facebook.com/mashable/' target='_social'></a></li>
<li><a class='twitter' href='https://twitter.com/mashable' target='_social'></a></li>
<li><a class='gplus' href='https://plus.google.com/+Mashable' target='_social'></a></li>
<li><a class='rss' href='http://feeds.mashable.com/Mashable' target='_social'></a></li>
<li><a class='pinterest' href='http://pinterest.com/mashable/' target='_social'></a></li>
<li><a class='youtube' href='http://www.youtube.com/user/mashable' target='_social'></a></li>
<li><a class='stumbleupon' href='http://www.stumbleupon.com/channel/Mashable' target='_social'></a></li>
<li><a class='linkedin' href='http://www.linkedin.com/today/mashable.com' target='_social'></a></li></ul>
<div class='about'>
<a class='brand' href='/'>
Mashable
</a>
<span class='blurb'>is a leading global media company that informs, inspires and entertains the digital generation. Mashable is redefining storytelling by documenting and shaping the digital revolution in a new voice, new formats and cutting-edge technologies to a uniquely dedicated audience of 42 million monthly unique visitors and 23 million social followers.</span>
</div>
<ul class='copyright-and-legal'>
<li>
&copy;2005-2015
Mashable, Inc.
</li>
<li>
Reproduction without explicit permission is prohibited. All Rights Reserved.
</li>
<li>
Designed in collaboration with <a rel="nofollow" href="http://www.codeandtheory.com">Code &amp; Theory</a>
</li>
</ul>
</div>
</footer>

<noscript>
<img src='http://b.scorecardresearch.com/p?c1=2&amp;c2=8750086&amp;cv=2.0&amp;cj=1'>
</noscript></div>
</div>
<div id='parsely-root' style='display: none'>
<span data-parsely-site='mashable.com' id='parsely-cfg'></span>
</div>
<script>
  loadScriptAsync("//static.parsely.com/p.js", "parsely")
</script>
</body>
</html>
